This review addresses the evolving role of metastasis-directed therapy (MDT) in the management of oligometastatic and oligoprogressive renal cell carcinoma (RCC). With advances in both surgical ...

The objective of this study is to evaluate the diagnostic performance of perineal access cannulas tethered to a biplanar ultrasound probe in cognitive transperineal prostate biopsies of targets ...

We performed a literature review to identify articles regarding the state of urological cancers in low-to-middle-income countries (LMICs). The challenges that LMICs face are multifactorial and can ...

All 189 World Bank member countries are classified by their per capita gross national income into one of four income groups. In this review, we aim to explore the economic burden and management of ...

A KLK3 germline variant analysed in 52,900 PCa patients and 40,470 disease-free controls across three independent cohorts is associated with reduced PCa risk, but, paradoxically, with poor survival ...

The gold standard for the treatment of localized upper tract urothelial carcinoma (UTUC) is radical nephroureterectomy (RNU) with excision of bladder cuff. Nevertheless, the specific benefits of ...

Immuno-oncology (IO) improves the prognosis of advanced renal cell carcinoma (RCC). Since research has so far been limited to clinical trials, we herein focused on the effects of IO-tyrosine kinase ...

The intermediate-risk non-muscle invasive bladder cancer (IR-NMIBC) prognostic group is heterogeneous. Growing evidence supports the role of active surveillance (AS) for patients with low-risk NMIBC, ...

Upper tract urothelial cancers (UTUC) are rare urothelial cancers that have historically been treated similarly to bladder urothelial cancers though outcomes have been worse than their lower tract ...

Survival differences in rare histological prostate cancer (PCa) subtypes relative to age-matched population-based controls are unknown. Within Surveillance, Epidemiology, and End Results database ...

Oral targeted therapies are a standard of care for men with advanced prostate cancer. However, these therapies are expensive, which may be a barrier to some, particularly the most economically ...

Testicular cancer predominantly affects adolescents and young adults (AYAs) aged 15-39 years. This study analyzed the global, regional, and national burden of testicular cancer among AYAs (1990 to ...